Jonathan Trent, MD
Enriched profileProfessor of Medicine; Associate Director, Clinical Research; Director, Sarcoma Medical Research Program (Bone and Soft-Tissue Sarcoma Group) · University of Miami Miller School of Medicine
Jonathan Trent is Professor of Medicine; Associate Director, Clinical Research; Director, Sarcoma Medical Research Program (Bone and Soft-Tissue Sarcoma Group) at University of Miami Miller School of Medicine. OpenAlex indexes 483 publications with 15,107 citations (h-index 60); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Jonathan C. Trent, M.D., PH. D., is Professor of Medicine at University of Miami Miller School of Medicine / Sylvester Comprehensive Cancer Center. The public record shows 483 publications with 15,107 citations (h-index 60), centered on Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 18 companies, 1 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Sarcoma Diagnosis and Treatment
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 180.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Sponsor: Deciphera Pharmaceuticals, LLC
Industry payments
Updated 15 Oct 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Deciphera Pharmaceuticals Inc.Program year202510 payments
- Daiichi Sankyo Inc.Program year20254 payments
- Exelixis Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
52%Opioid Agonist52%Tramadol Hcl100%Part D<11 patientsCancer & immunology
48%Kinase inhibitor48%Imatinib Mesylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
1 NIH research award on record, funded 2019–2026 per NIH RePORTER. The latest:
- Clinical Protocol and Data Management
University of Miami School of Medicine
FY2026$301,052P30CA240139
Congress activity
Updated 15 Oct 2026
148 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Association of NAB2–STAT6 distal fusion with risk level of metastatic disease and thoracic primary site.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.
Clinical cancer research
Article2026 - BCOR-Mutated Conventional and Dedifferentiated Chondrosarcoma: A Clinicopathologic Study.
Genes, chromosomes & cancer
Article2025 - Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.
Journal of clinical oncology
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal TumorsArticle1,223 citations2010
- 03Molecular Subtypes of<i>KIT/PDGFRA</i>Wild-Type Gastrointestinal Stromal TumorsArticle412 citations2016
- 04
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jonathan-trent-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/jtrentmdphd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
sylvester.org/doctors/profile/133342
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sylvester.org ↗ - ResearchGate
researchgate.net/profile/Jonathan-Trent-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/jtrentmdphd
Mentions by others
where others cite or feature them- Other
sciprofiles.com/profile/857689
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciprofiles.com ↗ - Other
onclive.com/view/sarcoma-chaired-by-jonathan-trent-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - Other
targetedonc.com/authors/jonathan-c-trent-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗ - Other
thepapcorps.org/dr-jonathan-trent
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thepapcorps.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
X (Twitter): @JTrentMDPhD -- "Jon Trent, MD, PhD, Director of Sarcoma and GIST at Sylvester Cancer"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - LinkedIn
LinkedIn: jtrentmdphd -- "Associate Director, Clinical Research; Director, Sarcoma Program - The Sylvester Comprehensive Cancer Center at The University of Miami"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Fellowship in Medical Oncology/Hematology
University of Texas MD Anderson Cancer Center (chief fellow), 1999-2002
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- MD and PhD in Cancer Biology
The University of Texas Health Science Center at Houston (McGovern Medical School)
1995verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Sarcoma Medical Research Program / Bone and Soft-Tissue Sarcoma Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Associate Director
Clinical Research, Sylvester Comprehensive Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Medical Advisory Board member
Sarcoma Foundation of America (curesarcoma.org)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curesarcoma.org ↗ - Editor/author
"Sarcomas: Evidence-based Diagnosis and Management"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →amazon.com ↗
Awards & honors
honors on the public record- Chickasaw Hall of Fame inductee (2019)
recognized for career as board-certified oncologist and sarcoma specialist
2019verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hof.chickasaw.net ↗ - Award for Excellence in Research
University of Texas MD Anderson Cancer Center, Division of Cancer Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hof.chickasaw.net ↗
Secondary affiliations
appointments beyond the home institution- Former faculty
University of Texas Graduate School of Biomedical Sciences at Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Former Associate Professor of Medicine
Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗
- Featured profile/video
Chickasaw.tv (tribal nation media, tied to Chickasaw Hall of Fame recognition)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chickasaw.tv ↗ - Featured in patient-advocacy piece on a sarcoma medical reference book he authored/edited
CS Foundation (Shayna's Fund)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →csfshayna.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Sznol, MD
University of Miami Miller School of Medicine
Joshua Hare, MD
University of Miami Miller School of Medicine
Dileep Yavagal, MD
University of Miami Miller School of Medicine
Felipe Medeiros, MD
University of Miami Miller School of Medicine
George Demetri, MD
Dana-Farber Cancer Institute; Professor of Medicine
Richard Gorlick, MD
The University of Texas MD Anderson Cancer Center
William Tap, MD
Memorial Sloan Kettering Cancer Center
Scott Schuetze, MD
University of Michigan Medical School